Seeking Alpha·United States·Tuesday, September 15, 2026 at 06:13 AM

Kestra targets $141M FY 2027 revenue and mid-70% gross margin in next few years as Q1 revenue reaches $31M

Translate

SA Transcript Insights Editor

Earnings Call Insights: Kestra Medical Technologies (KMTS) Q1 fiscal 2027

Management View

“Revenue advanced sequentially off a strong fourth quarter and grew 60% year-over-year to $31 million,” said (Founder, President, CEO & Director Brian Webster), alongside “gross margin of 56.5%,” which he said marked “the 11th quarter in a row of sequential

Seeking Alpha's Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.

View the original on Seeking Alpha →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.